Skip Navigation
Markets
Pre-Markets
U.S. Markets
Europe Markets
China Markets
Asia Markets
World Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics
White House
Policy
Defense
Congress
Expanding Opportunity
Europe Politics
China Politics
Asia Politics
World Politics
Video
Latest Video
Full Episodes
Livestream
Top Video
Live Audio
Europe TV
Asia TV
CNBC Podcasts
CEO Interviews
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Livestream
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Livestream
Menu
Make It
select
USA
INTL
Livestream
Search quotes, news & videos
Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
PRO
Livestream
Menu
Market Insider
Stocks making the biggest moves midday: JPMorgan, Moderna, Boeing, Cardinal Health, Chipotle & more
Published Tue, Jan 13 2026
12:37 PM EST
Updated Tue, Jan 13 2026
1:40 PM EST
Scott Schnipper
WATCH LIVE
Check out some of the companies making the biggest moves midday: JPMorgan Chase — The largest bank in the U.S. dropped more than 3%, trading near session lows, after investment banking fees fell, missing expectations. JPM's chief financial officer signaled that the banking industry could push back against President Donald Trump's call for a one-year 10% cap on credit card interest rates. Chipotle Mexican Grill — The fast-casual chain fell more than 3% after reaffirming its 2025 guidance, which points to a low single-digit percentage decline in comparable store sales. Chipotle named an interim chief marketing officer to replace the departing Chris Brandt. Moderna – Shares jumped more than 14%. Speaking at JPMorgan's health-care conference, Moderna CEO Stéphane Bancel projected the company's 2025 sales to land at roughly $1.9 billion, topping the midpoint of its early guidance. L3Harris Technologies — The defense contractor added 1% after partnering with the Defense Department to increase solid rocket motor capacity and pursuing an initial public offering of its missile business in the second half of 2026. Under the agreement, the U.S. would invest in the business through a $1 billion convertible preferred that would convert to common stock after an IPO. Boeing — The aerospace company rose more than 3% after it outsold Airbus in 2025 for the first time since 2018. In December, Boeing logged net orders for 174 planes, including more than 100 737 Maxes for Alaska Airlines. Boeing delivered 63 jetliners to customers last month. Option Care Health — The provider of at-home or non-hospital infusion services jumped 10%. Option Care released preliminary fourth-quarter results , issued initial 2026 financial guidance and doubled its buyback authorization to $1 billion. Cardinal Health — The drug distributor raised full-year guidance , sending shares nearly 4% higher. Cardinal expects adjusted earnings of at least $10 per share, above prior guidance of $9.65 to $9.86 a share. Delta Air Lines — The airline fell more than 3% after posting mixed fourth-quarter results . The airline earned an adjusted $1.55 per share, beating an LSEG consensus of $1.53 per share. Revenue of $14.61 billion, however, was just below a $14.69 billion estimate. Intel , AMD — KeyBanc upgraded both chip stocks to overweight, saying they each have upside of more than 30% thanks to a memory chip supercycle and outsized data center demand. Intel advanced nearly 8%, while AMD gained 6%. Travere Therapeutics — The biopharma stock tumbled 32% after receiving additional information requests from the FDA to characterize the clinical benefit of a drug to treat kidney disorder. PAR Technology — Shares rose more than 2% after announcing that Papa Johns is using foodservice technology from PAR Technology across its restaurants. Revvity — The health sciences company rallied almost 4% after releasing preliminary fourth-quarter revenue of $772 million, topping the $757 million expected by analysts polled by FactSet. Revvity said it expects its full-year adjusted earnings per share to exceed the upper end of prior guidance of $4.90 to $5 per share. — CNBC's Michelle Fox, Fred Imbert, Christina Cheddar-Berk and Darla Mercado contributed reporting